Morning ID2T , The End game has always been Human Cancer. The K9 early step off into a commercial deal was due to there being a ready market for the K9 Lymphoma Treatment.
Our Cancer Treatment would have had to be tested on K9's anyway as part of the process moving towards Human Treatments.
The Beagles Phase I test for palatability and efficacy also delivered staggeringly positive news .
The commercial step off the Human program to provide a specific K9 Cancer Treatment is a sound strategy to gain Royalty Baring Income from the Technology to provide funds for continuing Human Trials..
Now the Previous Human Trial also provided positive results but was halted to enable a Palatable pill to be formulated ,,2016.. at that stage PAA were also given regulatory permission to proceed with further Human Trials on the data gained from the small Human Cohort.
Understand your point but really Pharmaust should make it clear to the market this is a HUMAN TREATMENT program ,, and PAA engineered an option with Elanco to bring in funds ( circa 19 years of IP surrounding PAA Tech)..
If anything the dogs would be thinking "heck we are getting Human Quality treatment " not Humans thinking this is a K9 Pill.. but again that comes down to clear communication and the message that PAA put to market..
Yesterday was a sad day for performance , i have read the announcement several times ... didn;t take long...
I understand the ASX Regulations and they are tight ,, so you generally have to tone downn the ASX Release but your publicist pushes the boundaries later in "Paid Content" "Editorial" and "Pre written Articles from the company'' follow through to gain MC and have Value recognised.
eg our trials to be in a position to deliver a dossier to Elanco took circa 6 years .. and to reach for a number $20m,
Did yesterdays effort from the company reach anywhere near returning the funds invested to gain the data?? did it spring up the MC $20m
Has PAA Scientific Progress been recognised by the market??? NO , so PAA Management need to try harder ,, deliver the news again.. get Roger on the Phones, Get Interviews, gain recognition ,,, demonstrate where a return occurs for SH DIRECTLY...
If I may these are the words missing from every release from Pharmaust.
Value
Share holders
Return
Financial Benefits
Income
Gain
Commercial Return
Royalty Baring Payments
any form of excitement TBH.
Management are obviously satisfied with 20c Otherwise they would F(*&*(n do something.. hire a Publicist ,,seek professional Marketing Help from an established Australian Player..Ratlle cages and get noticed ,,, gain SP traction and attract investment ON MASS.
only regret is not trading the arse off this company .... more spikes than a hedgehog ,, less traction than a dragster on ice...
The greater the awareness the greater the participation.. pretty simple stuff ,,,
What actions will take us out of this quagmire ... Greater Investor Participation ,, AKA Demand for PAA shares ,,, how is that going to occur?? Only Management can drive this business and at the moment since 27.5c we have been in reverse......
Expand
(20min delay)